[Exhibition Information] 99th Annual Meeting of the Japanese Pharmacological Society | Nanion Technologies Japan

A patch clamp system that incorporates a patch clamp amplifier, achieving miniaturization and reduction of installation costs, allowing for easy data acquisition and verification.

This is a world-class patch clamp system capable of performing gigaseal recordings, optimal for safety testing/toxicity testing/pharmacological testing/screening of compounds at the cellular level in the functional structural analysis of ion channels, research on related diseases, and drug development processes. ■ No experience with manual patch clamping or difficult operations required ■ No need for microscope/vibration isolation table/manipulator/Faraday cage/puller ■ 20 to 50 data points per day ■ Automation from gigaseal formation to whole cell formation ■ Compatible with voltage-dependent and ligand-dependent channels through pipetting ■ Measurement of action potentials using current clamp is also possible ■ Supports a wide range of applications, enabling rapid assay system development ■ Reduces compound adsorption with borosilicate glass chips

• Other physicochemical equipment
• Analytical Equipment
• Patch clamp system

A world-class patch clamp system that is easy to operate for anyone, allowing for simple data acquisition and verification.

This is a patch clamp system of the world's smallest class that can perform gigaseal recordings, optimal for safety testing/toxicity testing/pharmacological testing/screening of compounds at the cellular level in the functional structural analysis of ion channels, research on related diseases, and drug development processes. 【Features】 ■ No need for manual patch clamp experience or difficult operations ■ No need for microscope, vibration table, manipulator, Faraday cage, or puller ■ 20 to 50 data points per day ■ Automation from gigaseal formation to whole cell formation ■ Compatible with voltage-dependent, ligand-dependent, and temperature-dependent channels ■ Options available for research on channel rhodopsins and mechanosensitive channels using light stimulation ■ Measurement of action potentials using current clamp is also possible ■ Supports a wide range of applications and enables rapid assay system development ■ Reduces compound adsorption with borosilicate glass chips ■ Optional temperature control (10 to 50°C), capable of extracellular/intracellular perfusion ■ Can be integrated with amplifiers such as HEKA and Axon *For details, please refer to the catalog available for download in PDF.

• Other physicochemical equipment
• Analytical Equipment
• Patch clamp system

Measurement of impedance and extracellular potential of iPS-derived cardiomyocytes.

This is a hybrid cardiotoxicity screening device capable of impedance measurement and extracellular potential measurement similar to MEA. It can detect not only cardiomyocytes but also the minute contractions of cancer cells and liver cells due to the effects of compounds. ■ Simultaneous measurement of impedance and extracellular potential ■ 96-well simultaneous measurement ■ Label-free measurement ■ Long-term monitoring capability ■ Electrical pacing & optical pacing (optional) ■ Comes with an incubation system (temperature, humidity, and CO2 control) ■ Includes multifunctional and excellent data analysis and graph creation software ■ Validated human iPS cells: iCell, iCell², AXOL CM, Cardiosight-S, MiraCell Cardiomyocytes, etc. ■ Compact desktop size: W20.5 x D18 x H11.7cm / 3.5kg (main unit)

• Other physicochemical equipment
• Other Analysis

The Langeendorff method has been transformed into the latest high-throughput technology, allowing for the measurement of contractile force in cardiomyocytes under physiological conditions similar to the natural environment of cardiac tissue.

The FLEXcyte 96, which transforms the conventional Langendorff method into the latest high-throughput technology, can measure the contractile force (mN/mm²) of cardiomyocytes for cardiotoxicity and safety evaluation, as well as drug screening, under physiological conditions similar to the native cardiac tissue environment, without missing even slight responses to cytotoxicity, regardless of whether in the chronic or acute phase, simultaneously in 96 wells. ■ Simultaneous measurement in 96 wells ■ Label-free measurement ■ Long-term monitoring possible ■ Optical pacing (optional) ■ Comes with an incubation system (temperature, humidity, CO2 control) ■ Includes multifunctional excellent data analysis and graphing software ■ Validated human iPS cells: iCell, iCell², AXOL CM, Cardiosight-S, MiraCell Cardiomyocytes, etc. ■ Compact desktop size: W20.5 x D18 x H11.7cm / 3.5kg (main unit)

• Other physicochemical equipment
• Other Analysis

[Instructor] Paulstar Communications Inc. Representative Director Koji Kita [Key Lecture Content] Have you ever felt that, despite entrusting work to Generation Z and young employees, they "don't seem to get started," "don't lead to the expected results," or "it's ultimately faster to do it myself"? Behind these situations are various factors, including the recognition gap between supervisors and young employees regarding "entrusting and being entrusted," how to communicate the purpose of the work, the approach, and the scope of discretion, as well as how to follow up after delegating tasks. In this seminar, we will practically explain "how to delegate work" to elicit proactive behavior, taking into account the perspectives and behavioral characteristics of Generation Z and young employees. We will share specific management techniques to help supervisors break free from the burden of work, encourage the autonomy and growth of young employees, and steadily lead to results.

[Speaker] Yoichiro Okuyama, Senior Researcher, Research Department, Hamagin Research Institute, Inc. [Key Lecture Content] In China, the operation of autonomous taxis began in 2021, and now fully unmanned robo-taxis are running in cities like Beijing and Shenzhen. Experiencing a ride reveals the evolution of technology through natural acceleration, smooth steering, and seamless deceleration. Currently, there are several thousand vehicles in operation, but projections suggest that by 2030, this number could exceed one million, accounting for 70% of the global total. What are the underlying factors driving the social implementation of robo-taxis in China? By incorporating local test ride experiences, we will analyze the revenue situation of robo-taxi operating companies and the outlook for market expansion based on data, exploring their future potential. [Lecture Items] 1. Personal experiences of test riding robo-taxis in China 2. Trends in the market size of robo-taxis in China and globally 3. Background of the advancing social implementation of robo-taxis in China 4. Public acceptance and actual usage 5. Performance and challenges of major robo-taxi companies 6. Will robo-taxis become widespread in Japan as well? 7. Q&A / Business card exchange

Daitō Shikō Co., Ltd. will exhibit at the "102nd Tokyo International Gift Show Autumn 2026," which will be held at Tokyo Big Sight from September 2 (Wednesday). At the exhibition venue, we plan to showcase new products including the A7 binder, popular foil-stamped goods, stationery, clear files, and more. If you are looking for SP tools, promotional items, or novelties, please be sure to visit our booth.

Our company will participate in the 1st High-Performance Materials Exhibition (within High-Performance Materials Week) as a member of the MGC Group. We will be showcasing various functional polycarbonate resins that can serve as alternatives to metals and ceramics, so please be sure to visit our booth.

In the health and medical fields, which are directly connected to people's lives, it is essential to carefully interpret the results of data analysis and utilize them in decision-making. This seminar will first introduce basic analytical methods using JMP 19 and explain the contexts in which each method can be applied. Next, we will discuss the thought process for making causal interpretations, such as "Did a certain treatment improve the condition?" and how to estimate causal effects using JMP Pro 19. - Comparison of results before and after treatment using paired t-tests - Group comparisons using t-tests - Group comparisons considering pre-treatment values through analysis of covariance - Distinguishing between correlation and causation - Estimation of causal treatment effects This seminar will introduce these basic analytical methods with demonstrations. Those without statistical expertise and those unfamiliar with JMP are also very welcome. ▼ Details & Registration https://www.jmp.com/ja/events/live-webinars/non-series/2026/09-11-health-medical-data